OHSU in the news

Despite soaring overdose rates, Americans face barriers to treatment

The Argus Observer December 14, 2022
Honora Englander, M.D., Ximena Levander, M.D., and Jessica Gregg, M.D., Ph.D., argue for a new approach to addiction treatment, calling for programmatic and policy changes that, they argue, could “begin to address disparities and inequities, and save lives”

Taking a ride on South Waterfront’s new electric pedicab shuttle

Bike Portland December 14, 2022
OHSU offers members and the public free rides on an electric pedicab -- replacing the gas-powered shuttle that used to take people from the tram to the OHSU Schnitzer parking lot. “I feel like I’m in that Portlandia sketch,” says Nic Lawton, the pedicab driver trying relentlessly to flag people down for free rides.

Sillajen gets back to business with cancer drug trials

Korea JoongAng Daily December 13, 2022
South Korean company Sillajen will start recruiting patients for a phase 1 clinical trial testing a new oncology drug; the OHSU Knight Cancer Institute is one of three American cancer centers participating in the trial.
See more stories